Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | TAF9 |
| Upstream (Parents) |
|---|
| (<<) ACTA2 → TAF9 |
| (<<) ACTN4 → TAF9 |
| (<<) ADAM19 → TAF9 |
| (<<) ATP2B4 → TAF9 |
| (<<) CASP9 → TAF9 |
| (<<) CSGALNACT2 → TAF9 |
| (<<) FGF5 → TAF9 |
| (<<) GNAQ → TAF9 |
| (<<) KCNJ2 → TAF9 |
| (<<) KLF7 → TAF9 |
| (<<) LYPLA2 → TAF9 |
| (<<) MAP2K3 → TAF9 |
| (<<) RAD51L3 → TAF9 |
| (<<) RAF1 → TAF9 |
| (<<) RNF111 → TAF9 |
| (<<) SEPW1 → TAF9 |
| Downstream (Children) |
|---|
| TAF9 → ARSA (>>) |
| TAF9 → ASNS (>>) |
| TAF9 → DNM1L (>>) |
| TAF9 → EN2 (>>) |
| TAF9 → HPS6 (>>) |
| TAF9 → HSPA14 (>>) |
| TAF9 → IL1A (>>) |
| TAF9 → IL1F7 (>>) |
| TAF9 → ITGB8 (>>) |
| TAF9 → IVL (>>) |
| TAF9 → KRT1 (>>) |
| TAF9 → MAP3K9 (>>) |
| TAF9 → MMP17 (>>) |
| TAF9 → MT1G (>>) |
| TAF9 → PRR5 (>>) |
| TAF9 → RPL26L1 (>>) |
| TAF9 → RPS6KA4 (>>) |
| TAF9 → TCEB1 (>>) |
| TAF9 → TEX10 (>>) |
